Patient safety is, and will always remain, Lilly’s highest priority   Eli Lilly and Company (India) commends the actions taken by the Haryana drug control authority in addressing counterfeit products falsely bearing the Mounjaro® (tirzepatide) brand name that were recently seized in Gurugram, Haryana. These seized counterfeit